Moxsh Overseas

NSE: MOXSH · Education

—
52W Range₹40 – ₹140

Limited coverage

We are not actively covering this company or have limited coverage today. Click to request coverage.

Snapshot

Unlock Moxsh Overseas's vital signs

Growth · Profitability · Valuation · Strength · Conviction

Company Overview

Business

Moxsh Overseas Educon Ltd provides counselling, guidance, and online coaching services for medical aspirants. The company operates across seven countries and is expanding into the primary healthcare sector through a chain of Edu-Clinics.

Business Model

The company generates revenue through educational consultancy, student counselling, and online coaching services. Future revenue streams are expected from the operation of primary healthcare clinics.

Growth Outlook

Growth is driven by the expansion of medical coaching services and the strategic launch of India’s first chain of primary healthcare clinics operated by doctors.

  • Operational Countries:7

Key Risks

  • Regulatory Risk. Changes in international medical education regulations or licensing requirements could impact student enrolment and service viability.
  • Execution Risk. The transition into the primary healthcare sector involves significant operational challenges and capital expenditure.
  • Market Competition. The education and healthcare sectors are highly competitive, which may pressure margins and market share.

Start your research today

Unlock AI insights, financials, peers and live data on Moxsh Overseas and 5,000+ companies — free.

Start your research

Peers · Education

CompanyMkt CapP/EEV/EBITDARev Gr YoYEBITDA MgnROEROCE1Y Return
Moxsh OverseasMOXSH
₹88 Cr———41.1%——+178.5%
Shanti Educational Initiatives LimitedSEIL
₹3,186 Cr424.27265.37-11.8%21.2%9.5%13.2%+69.8%
NIIT Learning Systems LimitedNIITMTS
₹3,032 Cr10.267.10—19.8%16.6%18.3%-42.7%
NIIT LimitedNIITLTD
₹1,253 Cr128.7021.2411.8%14.4%0.9%1.4%-19.4%
Global EducationGLOBAL
₹684 Cr26.6618.0028.2%40.8%21.6%27.7%+109.9%
AptechAPTECHT
₹534 Cr20.6210.438.6%9.4%9.8%14.4%-28.2%

As of Mar 2026

Financials